EMULATE BIO UK LTDActive

Company number 12561698Private limited companyIncorporated 2020

Key figures

£1,021,807+37.8%
Net assets 2024
+78.4%
Average annual growth 2021–2024
0500 k1 m1.5 m2021202220232024

EMULATE BIO UK LTD does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2024
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2021202220232024
Filed accounts2021–2024
2021202220232024
Profit for the year45,27152,19948,17927,558
Cash at bank and in hand21,384368,39837,49412,195
Total assets234,312608,653966,7381,165,119
Total liabilities54,398139,720225,074143,312
Net assets / total equity179,914468,933741,6641,021,807
Average number of employees5666

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2024

sales and marketing activities related to research and experimental development on biotechnology for and on behalf of the parent company

As described in the company's latest filed accounts.

Summary: EMULATE BIO UK LTD

Company

EMULATE BIO UK LTD is a private limited company registered with Companies House under company number 12561698. It was incorporated on 17 Apr 2020. Its status is active. The registered office is in Bristol (BS1). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files small company accounts. Profit for the year was £27,558. Net assets were £1,021,807, up 37.8% on the previous year. Cash at bank and in hand was £12,195. Total assets were £1,165,119 and total liabilities £143,312. The company had an average of 6 employees. Figures are available for 4 financial years (2021–2024).

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 30 Apr 2027.